Objective: The purpose is to study the left heart function

traditional Chinese medicine syndrome

the quality of life

amino-terminal fragment of pro-bnp(NT-proBNP) and the influence of inflammatory cytokines of the acute myocardial infarction (AMI) patients after(PCI) postoperative that took Tongxinluo capsules. Method: Sixty cases of patients with acute myocardial infarction after PCI were randomly divided into control group (30 cases) and observation group (30 cases). Patients in the control group took aspirin

100 mg/time

1 time/day

orally;Isosorbide mononitrate sustained-release tablets

30 mg/time

1 time/day

orally;Clopidogrel 75 mg/time

1 time/day

orally;Atorvastatin calcium 20 mg/time

1 time/day

orally. Based on the control group

patients in the observation group additionally took Tongxinluo capsules

4 capsules/time

3 times/day. The treatment lasted for 3 months. The levels of left ventricular function

the detection of serum tumor necrosis factor-α (TNF-α)

interleukin 6 (IL-6)

hypersensitive c-reactive protein level (hs-CRP) and the NT-proBNP were monitored. The pneuma deficiency and blood stasis and Seattle angina questionnaire (SAQ) score were recorded

as well as the major adverse cardiac events happening within 6 months. Result: The improvements left ventricular end-diastolic diameter (LVEDD)

left ventricular contraction at the end of the inner diameter (LVESD)

left ventricular ejection fraction (LVEF) and the stroke volume (SV) of observation group are all better than those of control group (P<0.05 or P<0.01). The levels of serum NT-proBNP

TNF-α

IL-6 and hs-CRP of observation group are lower than the control group (P<0.01). The score of pneuma deficiency and blood stasis of observation group is lower than the control group (P<0.01)

while the SAQ score of observation group is higher than that of control group (P<0.01). The cumulative incidence of the major adverse cardiac events of observation group is 13.3%

which is lower than 30.0% of the control group (P<0.01). Conclusion: Tongxinluo capsule can improve the cardiac function and ventricular remodeling of patients with acute myocardial infarction after PCI

relieve the clinical symptoms

improve the quality of life and reduce the incidence of adverse cardiac events. Patients can benefit from multiple aspects so that it is worthy of clinical use.